We have previously identified phospholipid metabolites, including choline, glycerophosphoethanolamine, and GPC, as potential novel biomarkers of obesity-associated insulin sensitivity when compared with obese insulin resistant and type 2 diabetes mellitus (T2D) individuals. This evidence concerns the gene INS and type 2 diabetes mellitus.